Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

CD4+ T cell responses in human viral infection: lessons from hepatitis C
Benedikt Binder, Robert Thimme
Benedikt Binder, Robert Thimme
Published January 6, 2020
Citation Information: J Clin Invest. 2020;130(2):595-597. https://doi.org/10.1172/JCI133222.
View: Text | PDF
Commentary Article has an altmetric score of 4

CD4+ T cell responses in human viral infection: lessons from hepatitis C

  • Text
  • PDF
Abstract

Liver disease as a result of chronic hepatitis C virus (HCV) infection is a global problem. While some HCV infections resolve spontaneously, viral persistence associates with compromised T cell immunity. In this issue of the JCI, Chen et al. and Coss et al. explored virus-specific CD4+ T cell response during HCV infection. Both studies evaluated the HCV-specific T cells of patients with different courses of infection. Chen et al. revealed that initial CD4+ T cell responses are similar during early infection and that T cell failure resulted from loss of the virus-specific T cells themselves. Coss et al. showed that HCV-specific CD4+ T cells temporarily recovered in some women following childbirth. These studies contribute to our understanding of CD4+ T cell functionality during different natural courses of infection, with the notable implication that restoring CD4+ T cell immunity might contribute to controlling HCV infection.

Authors

Benedikt Binder, Robert Thimme

×

Total citations by year

Year: 2025 2024 2023 2021 Total
Citations: 1 1 3 5 10
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (10)

Title and authors Publication Year
Liver diseases: epidemiology, causes, trends and predictions
Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z, Guo Y, Wang H, Dong E, Xiao J
Signal Transduction and Targeted Therapy 2025
The compensatory role of T cells from lymph nodes in mice with splenectomy.
Liu X, Sun Y, Su Y, Gao Y, Zhang T, Wang Q, Zhang X, Zhang D, Sun C, Li J, Li Z, Zhang B
Journal of Cellular and Molecular Medicine 2024
Modulating Immune Response in Viral Infection for Quantitative Forecasts of Drug Efficacy.
Costa B, Vale N
Pharmaceutics 2023
The Effects of Programmed Cell Death of Mesenchymal Stem Cells on the Development of Liver Fibrosis.
Wu HW, Chen HD, Chen YH, Mao XL, Feng YY, Li SW, Zhou XB
Stem Cells International 2023
Expression of the Hepatitis C Virus core-NS3 Fusion Protein on the Surface of Bacterial Ghosts: Prospects for Vaccine Production.
Tayebinia M, Sharifzadeh S, Rafiei Dehbidi G, Zare F, Ranjbaran R, Rahimi A, Miri MR, Mirzakhani M, Behzad-Behbahania A
Avicenna journal of medical biotechnology 2023
Human hepatitis D virus-specific T cell epitopes
M Kohsar, J Landahl, C Neumann-Haefelin, JS zur Wiesch
2021
A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection
ST Gobran, P Ancuta, NH Shoukry
Frontiers in immunology 2021
Towards a Systems Immunology Approach to Understanding Correlates of Protective Immunity against HCV
NH Shoukry
Viruses 2021
Applications of Mesenchymal Stem Cells in Liver Fibrosis: Novel Strategies, Mechanisms, and Clinical Practice
M Zhu, T Hua, T Ouyang, H Qian, B Yu, H Sumer
Stem Cells International 2021
T cell responses during HBV and HCV infections: similar but not quite the same?
Shoukry NH, Walker CM
Current Opinion in Virology 2021

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 5 X users
On 2 Facebook pages
16 readers on Mendeley
See more details